Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens

This publication has 48 references indexed in Scilit:

• The Classification of Lung Carcinoma: Time to Change the Morphology-Based Approach?
  International Journal of Surgical Pathology, 2010
• Clinical characteristics of pleomorphic carcinoma of the lung
  Lung Cancer, 2010
• Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis
  Journal of Thoracic Oncology, 2010
• EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti‐EGFR treatment of a rare lung malignancy
  International Journal of Cancer, 2009
• Pulmonary adenocarcinomas: classification and reporting
  Histopathology, 2009
• Review Article: Pulmonary Sarcomatoid Carcinomas: A Practical Overview
  International Journal of Surgical Pathology, 2009
• Survival prediction of stage I lung adenocarcinomas by expression of 10 genes
  Journal of Clinical Investigation, 2007
• Reliability of cytologic diagnosis of early lung cancer
  Cancer, 2007
• Why microscopy will remain a cornerstone of surgical pathology
  Laboratory Investigation, 2007
• Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers
  Diagnostic Cytopathology, 2005